Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy B. Riley Financial, Inc.

Arrowhead Pharmaceuticals Inc.
Start price
€74.86
30.07.26 / 50%
Target price
€107.38
30.07.27
Performance (%)
-0.77%
Price
€74.28
09:09
Summary
This prediction is currently active. Since the start of the prediction for Arrowhead Pharmaceuticals Inc. the price has only changed by -0.77%. This prediction currently runs until 30.07.27. The prediction end date can be changed by B__Riley_Financial__ at any time. B__Riley_Financial__ has 50% into this prediction
Performance without dividends (%)
Name 1w
Arrowhead Pharmaceuticals Inc. 0.916%
iShares Core DAX® -1,59 %
iShares Nasdaq 100 -4,15 %
iShares Nikkei 225® -6,30 %
iShares S&P 500 -3,23 %

Comments by B__Riley_Financial__ for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -0.77%
Target price 107.379
Change
Ends at 30.07.27

Arrowhead Pharmaceuticals (ARWR) had its price target raised by B. Riley Financial, Inc. from $101.00 to $123.00. They now have a "buy" rating on the stock.
Ratings data for ARWR provided by MarketBeat

B. Riley Financial, Inc. 
0
Report Share
30.07.26